TFRC and cancer: Furthermore, more frequently upregulated TFRC expressions occur in some drug-resistant human cancer cells (22), therefore requiring more in-depth studies to clarify the role of TFRC in the sensitivity and resistance of cancer cells to imatinib in GIST therapy.